Mitochondrial Membrane Protein-Associated Neurodegeneration (MPAN)

International Review of Neurobiology

Volumn 110, Issue , 2013, Pages 73-84

  Hartig, Monika ^a,b   Prokisch, Holger ^a,b,c   Meitinger, Thomas ^a,b,c,d   Klopstock, Thomas ^b,d,e  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b German Network for Mitochondrial Disorders (MitoNET)   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

C19orf12 gene; Extrapyramidal signs; Globus pallidus; Mitochondrial membrane protein associated neurodegeneration (MPAN); Motor axonal neuropathy; Neurodegeneration with brain iron accumulation (NBIA); Optic atrophy; Pyramidal signs; Substantia nigra

Indexed keywords

ALPHA SYNUCLEIN; GENOMIC DNA; MEMBRANE PROTEIN; MITOCHONDRIAL MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BIOACCUMULATION; BRAIN REGION; CLINICAL FEATURE; DIFFUSE LEWY BODY DISEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DNA SEQUENCE; GENE EXPRESSION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; IMAGE ANALYSIS; LOSS OF FUNCTION MUTATION; MITOCHONDRIAL MEMBRANE PROTEIN ASSOCIATED NEURODEGENERATION; MOLECULAR DYNAMICS; MOLECULAR EVOLUTION; MOLECULAR PATHOLOGY; NERVE DEGENERATION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; SEQUENCE ANALYSIS;

C19ORF12 GENE; EXTRAPYRAMIDAL SIGNS; GLOBUS PALLIDUS; MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION (MPAN); MOTOR AXONAL NEUROPATHY; NEURODEGENERATION WITH BRAIN IRON ACCUMULATION (NBIA); OPTIC ATROPHY; PYRAMIDAL SIGNS; SUBSTANTIA NIGRA;

HUMANS; IRON METABOLISM DISORDERS; MITOCHONDRIAL PROTEINS; MUTATION; NEUROAXONAL DYSTROPHIES;

EID: 84887240918     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-410502-7.00004-1     Document Type: Chapter

References (21)

1. Alazami A.M., Al-Saif A., Al-Semari A., Bohlega S., Zlitni S., Alzahrani F., et al. Mutations in C2orf37, encoding a nucleolar protein, cause hypogonadism, alopecia, diabetes mellitus, mental retardation, and extrapyramidal syndrome. American Journal of Human Genetics 2008, 83(6):684-691.
2. Curtis A.R., Fey C., Morris C.M., Bindoff L.A., Ince P.G., Chinnery P.F., et al. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nature Genetics 2001, 28(4):350-354.
3. Deschauer M., Gaul C., Behrmann C., Prokisch H., Zierz S., Haack T.B. C19orf12 mutations in neurodegeneration with brain iron accumulation mimicking juvenile amyotrophic lateral sclerosis. Journal of Neurology 2012, 259(11):2434-2439.
4. Dezfouli M.A., Alavi A., Rohani M., Rezvani M., Nekuie T., Klotzle B., et al. PANK2 and C19orf12 mutations are common causes of neurodegeneration with brain iron accumulation. Movement Disorders: official journal of the Movement Disorder Society 2013, 28(2):228-232.
5. Dogu O., Krebs C., Kaleagasi H., Demirtas Z., Oksuz N., Walker R., et al. Rapid disease progression in adult-onset mitochondrial membrane protein-associated neurodegeneration. Clinical Genetics 2012, 84(4):350-355.
6. Goldman J.G., Eichenseer S.R., Berry-Kravis E., Zimnowodzki S., Gregory A., Hogarth P., et al. Clinical features of neurodegeneration with brain iron accumulation due to a C19orf12 gene mutation. Movement Disorders: Official Journal of the Movement Disorder Society 2013, 28(10):1462-1463.
7. Haack T.B., Hogarth P., Kruer M.C., Gregory A., Wieland T., Schwarzmayr T., et al. Exome sequencing reveals de novo WDR45 mutations causing a phenotypically distinct, X-linked dominant form of NBIA. American Journal of Human Genetics 2012, 91(6):1144-1149.
8. Hallervorden J. Uber eine familiare Erkrankung im extrapyramidalen System. Deutsche Zeitschrift für Nervenheilkunde 1924, 81:204-210.
9. Harris Z.L., Takahashi Y., Miyajima H., Serizawa M., MacGillivray R.T., Gitlin J.D. Aceruloplasminemia: Molecular characterization of this disorder of iron metabolism. Proceedings of the National Academy of Sciences of the United States of America 1995, 92(7):2539-2543.
10. Hartig M.B., Hortnagel K., Garavaglia B., Zorzi G., Kmiec T., Klopstock T., et al. Genotypic and phenotypic spectrum of PANK2 mutations in patients with neurodegeneration with brain iron accumulation. Annals of Neurology 2006, 59(2):248-256.
11. Hartig M.B., Iuso A., Haack T., Kmiec T., Jurkiewicz E., Heim K., et al. Absence of an orphan mitochondrial protein, c19orf12, causes a distinct clinical subtype of neurodegeneration with brain iron accumulation. American Journal of Human Genetics 2011, 89(4):543-550.
12. Hayflick S.J., Westaway S.K., Levinson B., Zhou B., Johnson M.A., Ching K.H., et al. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. The New England Journal of Medicine 2003, 348(1):33-40.
13. Hogarth P., Gregory A., Kruer M.C., Sanford L., Wagoner W., Natowicz M.R., et al. New NBIA subtype: Genetic, clinical, pathologic, and radiographic features of MPAN. Neurology 2013, 80(3):268-275.
14. Hortnagel K., Prokisch H., Meitinger T. An isoform of hPANK2, deficient in pantothenate kinase-associated neurodegeneration, localizes to mitochondria. Human Molecular Genetics 2003, 12(3):321-327.
15. Kruer M.C., Paisan-Ruiz C., Boddaert N., Yoon M.Y., Hama H., Gregory A., et al. Defective FA2H leads to a novel form of neurodegeneration with brain iron accumulation (NBIA). Annals of Neurology 2010, 68(5):611-618.
16. Morgan N.V., Westaway S.K., Morton J.E., Gregory A., Gissen P., Sonek S., et al. PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron. Nature Genetics 2006, 38(7):752-754.
17. Panteghini C., Zorzi G., Venco P., Dusi S., Reale C., Brunetti D., et al. C19orf12 and FA2H mutations are rare in Italian patients with neurodegeneration with brain iron accumulation. Seminars in Pediatric Neurology 2012, 19(2):75-81.
18. Schneider S.A., Paisan-Ruiz C., Quinn N.P., Lees A.J., Houlden H., Hardy J., et al. ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation. Movement Disorders: Official Journal of the Movement Disorder Society 2010, 25(8):979-984.
19. Schottmann G., Stenzel W., Lutzkendorf S., Schuelke M., Knierim E. A novel frameshift mutation of C19ORF12 causes NBIA4 with cerebellar atrophy and manifests with severe peripheral motor axonal neuropathy. Clinical Genetics 2013, 10.1111/cge.12137.
20. Schulte E.C., Claussen M.C., Jochim A., Haack T., Hartig M., Hempel M., et al. Mitochondrial membrane protein associated neurodegenration: A novel variant of neurodegeneration with brain iron accumulation. Movement Disorders: Official Journal of the Movement Disorder Society 2013, 28(2):224-227.
21. Zhou B., Westaway S.K., Levinson B., Johnson M.A., Gitschier J., Hayflick S.J. A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nature Genetics 2001, 28(4):345-349.